Thiazolobenzoheterocycles, their preparation and medicaments containing them
AssigneeAventis Pharma S.A.
InventorsJean-Claude Hardy, Jean Bouquerel, Patrick Nemecek, Jean-Claude Aloup, Serge Mignani, Jean-François Peyronel
Life of this patent
Estimating the term…
Abstract
Compounds of formula (I): their racemates, enantiomers, diastereoisomers and inorganic acid salts and organic acid salts thereof, processes for preparing them and the medicaments containing them are discussed.
Claims13
A compound of formula (I):
- or a racemate, an enantiomer, a diastereoisomer or an inorganic or organic acid salt thereof,
- in which:
- R1 is a sulphur atom;
- R2 is a hydrogen atom or an alkyl radical;
- —R3—R4—R5— is a chain having the formula —CH2—CH2—N(R10)— or —CH2—CO—N(R10)—;
- R6 is a polyfluoroalkyl, polyfluoroalkoxy or polyfluoroalkylthio radical;
- and
- R10 is a hydrogen atom or an alkyl radical;
- wherein, unless otherwise indicated, said alkyl and alkoxy radicals and portions thereof have from 1 to 6 straight- or branched-chain carbon atoms.
A compound of formula (II):
- in which:
- —R3—R4—R5— is a chain having the formula —CH2—CH2—N(R10)— or —CH2—CO—N(R10)—;
- R6 is a polyfluoroalkyl, polyfluoroalkoxy or polyfluoroalkylthio radical;
- and
- R10 is a hydrogen atom or an alkyl radical;
- wherein, unless otherwise indicated, said alkyl and alkoxy radicals and portions thereof have from 1 to 6 straight- or branched-chain carbon atoms;
- with the proviso that the following compounds are excluded:
- 6-trifluoromethyl-1,2,3,4-tetrahydroquinoxaline and 2-oxo-7-trifluoromethyl-3,4-dihydroquinoxaline.
A pharmaceutical composition, said composition comprising a pharmaceutically effective amount of a compound of formula (I):
- or a racemate, an enantiomer, a diastereoisomer or an inorganic or organic acid salt thereof,
- in which:
- R1 is a sulphur;
- R2 is a hydrogen atom or an alkyl radical;
- —R3—R4—R5— is a chain having the formula —CH2—CH2—N(R10)— or —CH2—CO—N(R10)—;
- R6 is a polyfluoroalkyl, polyfluoroalkoxy or polyfluoroalkylthio radical;
- and
- R10 is a hydrogen atom or an alkyl radical;
- wherein, unless otherwise indicated, said alkyl and alkoxy radicals and portions thereof have from 1 to 6 straight- or branched-chain carbon atoms;
- and
- a pharmaceutically compatible diluent.
A process for the preparation of a compound of formula (I):
- or a racemate, an enantiomer, a diastereomer or an inorganic or organic acid salt thereof,
- wherein:
- R1 is a sulphur;
- R2 is a hydrogen atom;
- —R3—R4—R5— is a chain having the formula —CH2—CH2—N(R10)— or —CH2—CO—N(R10)—;
- R6 is a polyfluoroalkyl, polyfluoroalkoxy or polyfluoroalkylthio radical;
- and
- R10 is a hydrogen atom or an alkyl radical;
- wherein, unless otherwise indicated, said alkyl and alkoxy radicals and portions thereof have from 1 to 6 straight- or branched-chain carbon atoms;
- said process comprising:
- reacting an alkali metal thiocyanate with a compound of formula (II):
- wherein:
- —R3—R4—R5— is a chain having the formula —CH2—CH2—N(R10)— or —CH2—CO—N(R10)—;
- R6 is a polyfluoroalkyl, polyfluoroalkoxy or polyfluoroalkylthio radical;
- and
- R10 is a hydrogen atom or an alkyl radical;
- wherein, unless otherwise indicated, said alkyl and alkoxy radicals and portions thereof have from 1 to 6 straight- or branched-chain carbon atoms.
A process for the preparation of a compound of formula (I):
- or a racemate, an enantiomer, a diastereoisomer or an inorganic or organic acid salt thereof,
- wherein:
- R1 is a sulphur;
- R2 is an alkyl radical;
- —R3—R4—R5— is a chain having the formula —CH2—CH2—N(R10)— or —CH2—CO—N(R10)—;
- R6 is a polyfluoroalkyl, polyfluoroalkoxy or polyfluoroalkylthio radical;
- and
- R10 is a hydrogen atom or an alkyl radical;
- wherein, unless otherwise indicated, said alkyl and alkoxy radicals and portions thereof have from 1 to 6 straight- or branched-chain carbon atoms;
- said process comprising:
- alkylating a compound of formula (I)
- wherein:
- R1 is a sulphur;
- R2 is a hydrogen atom;
- —R3—R4—R5— is a chain having the formula —CH2—CH2—N(R10)— or —CH2—CO—N(R10)—;
- R6 is a polyfluoroalkyl, polyfluoroalkoxy or polyfluoroalkylthio radical;
- and
- R10 is a hydrogen atom or an alkyl radical;
- wherein, unless otherwise indicated, said alkyl and alkoxy radicals and portions thereof have from 1 to 6 straight- or branched-chain carbon atoms.
A method for making a pharmaceutical composition, said method comprising including, with a pharmaceutically compatible diluent, a pharmaceutically effective amount of a compound of formula (I):
- or a racemate, an enantiomer, a diastereoisomer or an inorganic or organic acid salt thereof,
- in which:
- R1 is a sulphur;
- R2 is a hydrogen atom or an alkyl radical;
- —R3—R4—R5— is a chain having the formula —CH2—CH2—N(R10)— or —CH2—CO—N(R10)—;
- R6 is a polyfluoroalkyl, polyfluoroalkoxy or polyfluoroalkylthio radical;
- and
- R10 is a hydrogen atom or an alkyl radical;
- wherein, unless otherwise indicated, said alkyl and alkoxy radicals and portions thereof have from 1 to 6 straight- or branched-chain carbon atoms.
Dependencies are inferred from the claim text.